Table 2.
Sample characteristics: MI vs. non-MI chest pain cases.
| Clinical concerns | Variables | Controls | Chest pain cases | Statistics | |
|---|---|---|---|---|---|
| (n = 84) | Non-MI (n = 61) | MI (n = 85) | p-values | ||
| Demographics | Male | 56 | 32 | 67 | 0.00 |
| Age (years) | 50.25 ± 1.76 | 60.18 ± 2.42 | 65.08 ± 1.60 | 0.12 | |
| Cardiac risk factors | Hypertension | 32 | 32 | 51 | 0.28 |
| Diabetes | 8 | 8 | 28 | 0.01 | |
| Tobacco use | 8 | 8 | 35 | 0.00 | |
| TC (mmol/L) | 4.93 ± 0.15 | 3.69 ± 0.12 | 4.28 ± 0.15 | 0.01 | |
| TG (mmol/L) | 1.43 ± 0.12 | 1.26 ± 0.09 | 1.65 ± 0.11 | 0.02 | |
| LDL-C (mmol/L) | 3.15 ± 0.11 | 2.40 ± 0.09 | 2.86 ± 0.11 | 0.01 | |
| HDL-C (mmol/L) | 1.31 ± 0.04 | 0.96 ± 0.03 | 0.94 ± 0.03 | 0.70 | |
| LPa (mg/L) | 349.35 ± 51.45 | 334.55 ± 47.64 | 341.96 ± 33.82 | 0.56 | |
| Prior cardiovascular disease | 2 | 12 | 10 | 0.24 | |
| Serum biomarkers | cTnT (ng/ml) | – | 756.13 ± 242.59 | 1,559.30 ± 276.64 | 0.56 |
| CK-MB (U/L) | – | 24.98 ± 6.08 | 32.10 ± 5.89 | 0.68 | |
| Mb (ng/ml) | – | 59.30 ± 23.79 | 66.99 ± 15.32 | 0.46 | |
| Biochemical items | ALT (U/L) | 27.15 ± 2.48 | 32.17 ± 4.59 | 43.14 ± 3.65 | 0.04 |
| AST (U/L) | 26.31 ± 1.45 | 29.12 ± 2.91 | 102.99 ± 14.10 | 0.00 | |
| LDH (U/L) | 169.30 ± 3.85 | 213.05 ± 10.22 | 497.43 ± 45.36 | 0.00 | |
| CK (U/L) | 119.30 ± 11.27 | 86.83 ± 12.99 | 690.51 ± 113.49 | 0.00 | |
| HBDH (U/L) | 107.80 ± 3.87 | 132.79 ± 6.71 | 384.89 ± 40.81 | 0.00 | |
| TP (g/L) | 70.80 ± 0.47 | 61.95 ± 0.71 | 60.68 ± 0.62 | 0.18 | |
| GLU (mmol/L) | 5.77 ± 0.13 | 5.49 ± 0.22 | 6.28 ± 0.32 | 0.06 | |
| Ca (mmol/L) | 2.36 ± 0.02 | 2.20 ± 0.02 | 2.16 ± 0.02 | 0.11 | |
Values are presented as mean ± SE. The Mann–Whitney U-test was applied to produce p-value between MI and non-MI chest pain cases. Bold values are abnormal findings of the test results.